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INTRODUCTION
Central nervous system (CNS) damage resulting from irra-
diation is most often characterized by vascular abnormalities,
demyelination and, ultimately, necrosis. In the intraoperative
radiotherapy (IORT), Matsutani et al. reported that localized
necrosis developed in 32% of patients (1), and we previously
observed radiation necrosis in the normal rat brain 8 weeks
after experimental IORT using 10 Gy (2). Although the
pathogenesis of radiation necrosis is not fully understood, it
is possible that vascular endothelial cell injury is one of sev-
eral major culprits. Acute vascular changes within 24 hr after
irradiation include increased endothelial cell swelling, vascu-
lar permeability and edema, lymphocyte adhesion and infil-
tration, and apoptosis (3, 4). Late vascular effects occur weeks
to months after irradiation and include capillary collapse,
thickening of basement membranes, scarring and fibrosis,
telangiectasias, and a loss of clonogenic capacity. Despite the
importance of radiation effects on the angiogenesis in the
CNS, there are limited knowledge and in vivo data on the
role of growth factors. 
Growth factors currently appear to be the central media-
tors of angiogenesis and vascular permeability. The fibro-
blast growth factor (FGF) family is composed of at least nine
related mitogens that affect a variety of cells of neuroectoder-
mal or mesenchymal origin. FGF1 or acidic FGF, and FGF2
or basic FGF, have 53% sequence homology (5). They have
a strong affinity for heparin and are often associated with the
heparin sulfate proteoglycans present in the basement mem-
brane and extracellular matrix. FGF2, also described as a fibro-
blast mitogen and isolated from bovine pituitary glands and
brains, is known to be synthesized by a variety of tumor and
endothelial cells (6). It is found in reactive astrocytes and neu-
rons (7, 8). Since it has been known as a potent mitogen for
astroglial cells, this factor is also known to be capable of stim-
ulating the replication of multiple cell types including astro-
cytes (9). Furthermore, FGF2 is a direct angiogenic factor
that promotes every phase of the angiogenic process and in-
duces in vitro synthesis of plasminogen activator, a serine
protease that plays a critical role in the angiogenetic process
and other processes (10).
Vascular endothelial growth factor (VEGF) is a 36,000 to
46,000 Da dimeric glycoprotein with a potent and specific
activity for endothelial cell proliferation in vivo (11). VEGF,
also known as vascular permeability factor, was originally
found to be secreted by tumor cells causing venules and small
veins to become hyperpermeable to circulating macromole-
cules (12). In CNS tumors, expression of VEGF is associated
with tumor vascularity and peritumoral edema (13). Its ex-
pression is upregulated in the presence of hypoxia, and VEGF
mRNA is preferentially expressed in tumor cells on the periph-
ery of necrotic areas, i.e. areas of hypoxia (14). Because radi-
ation necrosis also exists in hypoxic regions on the peripheral
necrotic areas, it is conceivable that VEGF may play a critical
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Upregulation of VEGF and FGF2 in Normal Rat Brain after
Experimental Intraoperative Radiation Therapy
The expression of vascular endothelial growth factor (VEGF) and fibroblast growth
factor (FGF)2 in the irradiated brain was examined to test how a single high dose
radiation, similar to that used for intraoperative radiation therapy given to the normal
cerebrum, can affect the vascular endothelium. After a burr hole trephination in the
rat skull, the cerebral hemisphere was exposed to a single 10 Gy dose of gamma rays,
and the radiation effect was assessed at 1, 2, 4, 6, and 8 weeks after irradiation. His-
tological changes, such as reactive gliosis, inflammation, vascular proliferation and
necrosis, were correlated with the duration after irradiation. Significant VEGF and
FGF2 expression in the 2- and 8-week were detected by enzyme-linked immunosorbent
assay quantification in the radiation group. Immunohistochemical study for VEGF was
done and the number of positive cells gradually increased over time, compared with
the sham operation group. In conclusion, the radiation injuries consisted of radiation
necrosis associated with the expression of VEGF and FGF2. These findings indicate
that VEGF and FGF2 may play a role in the radiation injuries after intraoperative
single high-dose irradiation.
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role in single high-dose irradiation.
In this study, we investigated whether VEGF and FGF2
are upregulated by single high-dose irradiation, similar to
that used for IORT given to the normal brain. Our results
were consistent with the hypothesis that the majority of
delayed vascular changes observed in the irradiated normal
brain are due to irradiation-induced upregulation of VEGF
and FGF2.
MATERIALS AND METHODS
One hundred Sprague-Dawley rats weighing 350-400 g
were used irrespective of their sex. The rats were given water
and food ad libitum until the experiment was conducted.
Single high-dose irradiation and forebrain extirpation
One percent ketamine (50 mg/kg), known to have no radio-
protective effect, was intraperitoneally injected and then the
heads were fixed to a head holder (SN-8N Semichronic Head
holder, Narishige Co., Tokyo, Japan) in a ventral decubitus
position. A longitudinal incision was made on the scalp along
the median line. Under operative microscopy, an 8-mm diam-
eter hole was drilled on the right parietal area to expose the
dura mater. Because it was technically impossible to conduct
intraoperative irradiation using electron beams on a tiny rat
brain, iridium-192 (GammaMed 12i, MDS Nordion, Cana-
da), which has the same characteristics as the electron beam
and is commonly used for high-dose rate brachytherapy, was
used instead as a source of radiation. A shield was made of
Lipowitz metal (Cerroben
�, MED-TEC, Orange, IA, U.S.A.),
and then a 0.6-cm hole was made in the middle to ensure
that the iridium source was located 0.5 cm above the hole.
The source was located sufficiently distant so that the impact
of diffused beams on the irradiation site could be minimized,
a 1-cm diameter portion on the surface of the rat brain could
be exposed to radiation, and intraperitoneally 10 Gy could
be irradiated by a single irradiation on the brain surface 2 cm
away from the source (Fig. 1). The 10 Gy dose was selected
because it is known as the lowest dose to have a radiation
effect during intraoperative irradiation. After irradiation, the
scalp was sutured in an aseptic condition with absorbable
thread. Fifty rats were divided into 5 groups of 10 each, and
their forebrains were extirpated at 1, 2, 4, 6, and 8 weeks
after irradiation. As the sham operation (control) group, 50
non-irradiated rats also underwent forebrain extirpation at
the same time intervals as the irradiation group.
Histopathological examination
The extirpated brains were fixed in 10% buffered formalin
for 6 hr to maintain their antigenicity. A coronal section slice
of 5-mm anteroposterior diameter was made centered around
the irradiated portion. According to the usual tissue process-
ing procedure, tissues were passed through ethanol for dehy-
dration and embedded in paraffin, after which a thin, 5- m
thickness section was made and H-E stained.
Quantitative analysis of VEGF and FGF2 using enzyme-
linked immunosorbent assay (ELISA)
Using the quantitative sandwich ELISA method with an
ELISA kit (Quantikine
�, R&D Systems, Minneapolis, MN,
U.S.A.), we quantified the expression of VEGF and FGF2
in the irradiated right hemispheres. To extract the protein,
the paraffin-embedded tissues were sectioned at 10- m thick-
ness, and processed in 100% xylene for 5-10 min at room
temperature for deparaffinization. Then they were centrifuged
at 13,000 rpm for 3 min twice, and left in 95% acetone at
room temperature for 5 min. Again, they were centrifuged
at 13,000 rpm for 3 min twice and washed in distilled water
for 10 min. After 100  L of protein lysis buffer was added to
each tube, they were left at 4℃ for 1 hr, and then centrifuged
at 1,000 rpm for 30 min. Then, the upper layer was separat-
ed for the quantitation of protein according to the Bradford
method. The specimen was diluted with a coating buffer to
make 2  g/mL, after which 100  L/well was put into a 96-
well plate. The plate was covered, incubated at 37℃for 2 hr,
and then washed with 200  L/well phosphate-buffered saline
Tween-20 (PBST) 3 times at intervals of 3-4 min. With an
addition of 3% bovine serum albumin at 200  L/well, the
Fig. 1. Schematic drawing of a burr hole trephination and irradia-
tion. a: diameter of radiation tube, 6 mm; b: distance from Ir-192
source to shield end, 5 mm; c: distance from source to brain sur-
face, 20 mm (Not drawn to scale).
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plate was further incubated for 2 hr at 37℃, and again washed
3 times with PBST. The plate was incubated with primary
antibody diluted at 1:200 with PBST (100  L/well) at 37℃
for 2 hr, and washed 3 times with PBST. Then, it was incu-
bated with secondary antibody diluted at 1:1,500 with PBST
(100  L/well) at 37℃ for 2 hr, and washed 3 times with
PBST. Finally, with an addition of substrate peroxidase buffer
(100  L/well), it was left at room temperature for 20 min for
a reaction, and 50  L/well of 5N H2SO4 was added to stop
the reaction. By measuring the concentration with a precision
microplate reader with an ultraviolet length of 450 nm (Molec-
ular Devices, Sunnyvale, CA, U.S.A.), VEGF and FGF2 were
quantified. The expression of VEGF and FGF2 over time after
irradiation was measured in each experimental group (irra-
diated right cerebral hemisphere), and then the values were
compared with bilateral hemispheres of the sham operation
group.
Immunohistochemical staining of VEGF and FGF2
A paraffin section was heated in an incubator at 56-58℃
for 30 min, and then deparaffinized and dehydrated at room
temperature. To restrict the endogenous peroxidase activity,
the section was incubated with methanol and 0.3% hydrogen
peroxide for 10 min, and then washed 2-3 times with phos-
phate-buffered saline (PBS, pH 7.4) for 5 min. Next, it was
processed with a blocking solution (non-immune sheep serum,
DAKO kit 1:5, Carpinteria, CA, U.S.A.) at room tempera-
ture for 20 min. The specimen was incubated with mono-
clonal anti-VEGF (Mouse monoclonal Ig G2a, Santa Cruz
Biotechnology, CA, U.S.A.) and FGF2 (Polyclonal rabbit
IgG, Oncogene, Cambrige, MA, U.S.A.) diluted at 1:100
in PBS at room temperature for 1 hr. Goat anti-mouse anti-
body, biotin-labeled secondary antibody, and avidin-biotin
complex were administered for 1 hr each. After a 10-min
incubation with 3.3-diaminobenzidine tetrahydrochloride as
a substrate for a color reaction, the specimen was stained with
Mayer’s hematoxylin, sealed up with a glycerol mounting
medium (DAKO-PATTS), and observed under an optical
microscope. As a positive control for the expression of VEGF
and FGF2, the spleen and tonsillar tissues were used. With
the help of a pathologist, the cells, with their nuclei stained
dark brown over the whole scope of the coronal section on
the irradiated cerebral cortex, were checked using an optical
microscope at a 200 magnification. The expression of VEGF
and FGF2 over time after irradiation was compared between
experimental groups.
Statistical analyses
The expression of VEGF and FGF2 over time after irradi-
ation was statistically analyzed using Sigmastat for Windows
version 1.0 (Jandel Corp., San Rafael, CA, U.S.A.). One-way
ANOVA and unpaired t-test were used to verify the measure-
ments within each experimental group, and unpaired t-test
was used to verify the differences in measurements between
the radiation and control groups. Results are expressed as
mean±SD for ELISA analysis and mean±SE for immuno-
histochemical staining analysis.
RESULTS
Histopathology over time after irradiation
A gradual loss of the outermost molecular layer was shown
over time after irradiation, and early cerebral change 1 and
2 weeks after intraoperative irradiation included reactive
gliosis, edema, and appearance of inflammary cells. Subacute
change 6 and 8 weeks after intraoperatvie irradiation includ-
ed severe loss of the outermost molecular layer, fibrosis, appear-
ance of inflammatory cells, proliferation of vascular endothe-
lial cells, collapse of the white matter and necrosis (Fig. 2).
Quantitative analyses of VEGF and FGF2 over time after
irradiation
The expressions of VEGF and FGF2 in the radiation and
sham operation groups were quantified. At 1, 2, 4, 6, and 8
weeks, the concentration of VEGF in the radiation group was
5.74±0.01 pg/mL, 10.09±0.14 pg/mL, 12.08±0.14 pg/
mL, 12.12±0.25 pg/mL, and 14.56±0.52 pg/mL, respec-
tively, as compared with 6.18±0.05 pg/mL, 9.70±0.30 pg/
mL, 12.86±0.51 pg/mL, 14.14±0.13 pg/mL, and 14.29±
0.36 pg/mL in the right hemisphere of the sham operation
group (craniectomy site) and 5.18±0.01 pg/mL, 7.85±0.01
pg/mL, 10.27±0.02 pg/mL, 11.42±0.02 pg/mL, and 11.43
±0.09 pg/mL in the left hemisphere (non-craniectomy site)
(Fig. 3A). Whereas the concentration of VEGF in the radia-
tion group was significantly higher than in the right hemi-
sphere of sham operation group at 2 weeks, the expression
showed a decrease at 1, 4, and 6 weeks (p<0.05). Although
the concentration of VEGF at 8 weeks was higher than at 6
weeks in both groups, there was a significantly steep slope
of expression in the radiation group between 6 and 8 weeks
(p<0.05). As compared with the left hemisphere of the sham
operation group, the concentration of VEGF in the radiation
group was significantly increased at 1, 2, 4, 6 and 8 weeks
(p<0.05).
At 1, 2, 4, 6, and 8 weeks, the concentration of FGF2 in
the radiation group was 4.99±0.04 pg/mL, 8.47±0.08 pg/
mL, 10.18±0.59 pg/mL, 10.22±0.42 pg/mL, and 12.14±
0.32 pg/mL, respectively, as compared with 5.48±0.38 pg/
mL, 8.20±0.19 pg/mL, 10.79±0.22 pg/mL, 11.91±0.30
pg/mL, and 11.85±0.14 pg/mL in the right hemisphere of
the sham operation group and 4.46±0.01 pg/mL, 6.65±
0.01 pg/mL, 8.65±0.01 pg/mL, 9.60±0.01 pg/mL, and
9.60±0.01 pg/mL in the left hemisphere (Fig. 4A). Whereas882 J.H. Kim, Y.G. Chung, C.Y. Kim, et al.
the concentration of FGF2 in the radiation group was signif-
icantly higher than that in the right hemisphere of the sham
operation group at 2 and 8 weeks, the expression was reduced
at 1, 4, and 6 weeks (p<0.05). While the concentration of
FGF2 at 8 weeks was less than that at 6 weeks in the right
hemisphere of the sham operaion group, there was a signifi-
cantly steep increase of expression in the radiation group
between 6 and 8 weeks, similar to that in the VEGF study
(p<0.05). As compared with the left hemisphere of the sham
operation group, the concentration of FGF2 in the radiation
group was significantly increased at 1, 2, 4, 6 and 8 weeks
(p<0.05).
Immunohistochemical analyses of the expression of VEGF
and FGF2
The cell count of immunohistochemical staining for VEGF
in the radiation group, at 1, 2, 4, 6, and 8 weeks, was 10.38
±1.45 cell/×200, 17.50±1.65, 25.00±1.46, 31.14±
2.90, and 44.40±4.83, respectively, which showed a signif-
icant increase as compared with 6.25±1.18, 13.29±1.38,
15.50±2.57, 11.43±1.00, and 8.25±1.21 in the right
hemisphere of the sham operation group (unpaired t-test, p<
0.05), respectively. The expression of VEGF was significant
increased within the radiation group over time after irradia-
Fig. 2. Morphologic changes after irradiation (H&E, ×12). Accord-
ing to the time intervals, loss of cortical thickness is increased and
reactive gliosis, proliferation of vascular endothelial cells, and cystic
necrosis become prominent. (A) 1 week, (B) 2 weeks, (C) 4 weeks,
(D) 6 weeks, (E) 8 weeks . 
A B
C
E
Dtion (p<0.05).
Immunohistochemical staining for FGF2 showed severe
cross reactivities, so that the results could not be interpreted.
DISCUSSION
IORT enables the intraoperative direct examination of
tumors and delivery of a great amount of radiation on the
tumor site, which can maximize the radiation effect and effec-
tively prevent the recurrence of tumors (15). Although the
risk for normal-tissue injury in the radiotherapeutic manage-
ment of brain tumors is of major clinical concern, the specific
cellular and molecular processes comprising the radioresponse
of the CNS remain to be delineated. Furthermore, it has been
speculated that normal brain damage by high dose irradia-
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Fig. 3. (A) Expression of VEGF according to the time after irradiation. Whereas the level of expression of VEGF was significantly higher
than in the right hemisphere(craniectomy site) of the sham operation group at 2 weeks, the expression showed a significant decrease at
1, 4, and 6 weeks (unpaired t- test, p<0.05). As compared with the left hemisphere (non-craniectomy site) of the sham operation group,
the concentration of VEGF in the radiation group was significantly increased at 1, 2, 4, 6 and 8 weeks (p<0.05). (B) Although the concen-
tration of VEGF at 8 weeks was higher than at 6 weeks in both groups, there was a significantly steep slope of expression in the radiation
group between 6 and 8 weeks (unpaired t-test, p<0.05). a: right hemisphere (craniectomy site) in the radiation group; b: right hemisphere
(craniectomy site) in the sham operation group; c: left hemisphere (non-craniectomy site) in the sham operation group.
*p<0.05 by unpaired t-test within the radiation group; 
� p<0.05 by unpaired t-test compared between radiation and sham operation groups; 
� p<
0.05 by unpaired t-test compared between right hemisphere of the radiation group and left hemisphere of the sham operation group.
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Fig. 4. (A) Expression of FGF2 according to the time after irradiation. Whereas the level of expression of FGF2 was significantly higher at
2 and 8 weeks than in the right hemisphere (craniectomy site) of the sham operation group, the expression showed a significant decrease
at 1, 4, and 6 weeks (unpaired t-test, p<0.05). As compared with the left hemisphere (non-craniectomy site) of the sham operation group,
the concentration of FGF2 in the radiation group was significantly increased at 1, 2, 4, 6 and 8 weeks (p<0.05). (B) While the concentra-
tion of FGF2 at 8 weeks was lower than that at 6 weeks in the sham operation group, there was a significantly steep incline of expression
in the radiation group between 6 and 8 weeks, similar to that in the VEGF study (unpaired t-test, p<0.05). a: right hemisphere (craniecto-
my site) in the radiation group; b: right hemisphere (craniectomy site) in the sham operation group; c: left hemisphere (non-craniectomy
site) in the sham operation group.
*p<0.05 by unpaired t-test within the radiation group, 
� p<0.05 by unpaired t-test compared between radiation and sham operation groups,
� p<0.05 by unpaired t-test compared between right hemisphere of the radiation group and left hemisphere of the sham operation group.
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A Btion during operation may be different from that by relatively
low radiation, so-called conventional radiotherapy or single
high dose irradiation before or after operation. Only a few
studies have been done on radiation injuries after single high-
dose irradiation, such as radiation necrosis and apoptosis.
According to Calvo et al. (16), the incidence of necrosis in
the cerebral white matter of the rat after high-dose irradia-
tion is closely related to the amount of radiation and the lapse
of time after irradiation, and these effects were associated with
a more serious injury of cerebral tissues because of necrosis
and proliferation of vascular endothelial cells. Our study also
found that over the subacute stage after irradiation of 10 Gy
on normal rat cerebral tissues, fibrous gliosis, appearance of
inflammatory cells, proliferation of vascular endothelial cells,
and necrosis gradually increased over time.
VEGF plays an important role in angiogenesis in the devel-
oping CNS (17), but its expression is significantly downreg-
ulated in the adult CNS after angiogenesis ceases. It is well
established that under hypoxic conditions, upregulation of
VEGF mRNA and protein occurs (18, 19). In our series, im-
munohistochemical studies disclosed strong VEGF-positivity
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Fig. 5. Immunohistochemical stain for VEGF of rat brain at 1 and 8 weeks after irradiation, ×400. In acute stage, there are no prominent
changes in the radiation group compared to the sham operation group. According to the time interval, the cellularity becomes more promi-
nent and stained cell counts are increased markedly in the white matter of the radiation group. (A) 1 week in the control group, (B) 1 week
in the radiation group, (C) 8 weeks in the control group, (D) 8 weeks in the radiation group.
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Fig. 6. The changes of the mean VEGF staining cell counts under
×200 magnification after irradiation. Values are expressed as
mean±standard errors. 
*p<0.05 by one way ANOVA within the radiation group. 
� p<0.05
by unpaired t-test compared between radiation and sham oper-
ation groups.
Sham operation group
*
*
,�
*
,�
*
,�
*
,�in the radiated normal brain in the subacute stage. Hypoxia
was found to be a potent inducer of VEGF expression in sev-
eral organs including the CNS (20). In a tumor, VEGF is local-
ized in the most ischemic and necrotic areas of the tissues, con-
sistent with the notion that local hypoxia is a potent inducer
of VEGF production (21). In non-neoplastic conditions, VEGF
is secreted in significant quantities by activated macrophages
and microglial cells in response to hypoxic conditions asso-
ciated with ischemic stroke (22). Thus, VEGF up-regulation
in the present study may provide further evidence for the pres-
ence of hypoxic condition associated with radiation-induced
necrosis.
VEGF mRNA induction by radiation has been demon-
strated recently in the neonatal rat spinal cord irradiated by
a very high dose of 55 Gy, with an increase in the vascular
density being observed at 4 to 5 weeks after irradiation (23).
This is in contrast to other reports that showed a degenera-
tive response of the vasculature in the adult CNS following
irradiation (24). Although they suggested that the prolifera-
tive response observed in their study might be due to the very
young age of the animals that were irradiated at postnatal
day 0 and 3, we considered that tissue damage associated with
angiogenesis and necrosis is one of causes of VEGF expres-
sion in subacute period. In the study of delayed cytokines
response to brain irradiation without operation, the level of
TNF- mRNA is re-elevated during the subacute time peri-
od, 2-3 months after 25 Gy irradiation, and is still elevated
at 6 months (25). This data suggest that cytokines such as
TNF- may be involved in late brain responses to irradia-
tion and could contribute to clinical symptoms. In our study,
ELISA and immunohistochemial studies showed that VEGF
was strongly expressed since the subacute time period.
Responses to the irradiation after craniectomy include sev-
eral tissue reactions such as inflammation, cerebral edema by
traumatic brain injury and ischemia except radiation injury.
VEGF expression in inflammatory cells, including plasma
cells and macrophages, has been previously described in the
tumors and in non-neoplastic conditions of the brain, such
as in the retina of diabetics, cerebral infarct, cerebral abscess,
or after nervous system trauma (26). VEGF is increased in
CSF after pediatric traumatic brain injury and the peak VEGF
occur at 22.4 hr after injury (27). By 72 hr after injury, the
mean VEGF concentration maintains approximately 1.8 times
of control and remains elevated 8 days after injury. In ischemic
conditions, there was a significant increase in the expression
of serum VEGF, which reach a peak after 7 days and remain
elevated after 14 days (28). Therefore, it is conceivable that
the increase of expression of VEGF of the control group is
related to various tissue reactions, including inflammation,
brain tissue injury due to craniectomy, and focal ischemia
and can remain elevated after 8 weeks. On the other hand,
the volume of irradiated-hemisphere was markedly reduced
at 6 and 8 weeks and necrotic tissue that does not have VEGF-
expressing cells, such as astrocytes, microglial cells, and macro-
phages, was prominent. Therefore, the concentration of VEGF
to the unit volume using the ELISA method could showed a
greater increase in the control group than in the radiation
group in 6 and 8 weeks. To eliminate these reactions, we also
used non-operated hemisphere (left hemisphere) in the sham
operated rats as the other control. This result showed that the
expression of VEGF was also increased in the left cerebral he-
mispheres, although the increase was smaller than that in the
right hemispheres. Although the mechanism is unclear, these
results suggest the possibilities of inflammation caused by
craniectomy or migration of macrophages to the opposite
hemispheres from the right hemisphere or inflow of cytokines
through the tissue fluid. The concentration of VEGF between
6 and 8 weeks rapidly increased in the radiation group, whereas
that in the control group stabilized. These results indiate that
the VEGF expression is markedly increased during this period
after experimental IORT, when we considered that the number
VEGF-expressing cells of unit area in the irradiated group is
smaller than control. Furthermore, there was a gradual increase
in cells that expressed VEGF in the irradiated white matter
except necrotic tissue over time.
FGF2 was first demonstrated in the bovine corneal base-
ment membrane and developing retinal capillaries (29). Endo-
thelial cells synthesize and store FGF2 within the cells and
their extracellular matrix, which in vivo includes the base-
ment membrane of the microvascular wall. Folkman et al.
hypothesized that tissue injury could release FGF2, thereby
triggering angiogenesis (30). The FGF2 may also serve as a
reservoir for the vascular mitogen. The FGF2 exists as either
a stable, inactive molecule or a rapidly degradable, bioactive
one (31). The active form of FGF2 stimulates endothelial cell
mitosis, migration, and remodeling of basement membranes,
which are three major steps in the process of angiogenesis.
FGF has been shown to exert radioprotective effects in several
non-CNS tissue systems in vivo and serves as an antiapoptotic
survival factor for endothelial cells irradiated in vitro and in
a lung model in vivo (4, 32). The present study showed that
the concentration of FGF2 in the normal brain was also in-
creased over time after irradiation. We thought that the in-
crease of FGF2 in the control group is related to operation-
induced tissue injury. Expression of FGF2 in the radiation
group was increased at the subacute stage and these results
suggest that FGF2 might play a major role in the normal
brain after single high-dose irradiation.
In the present study, we found that the expressions of VEGF
and FGF2 in the irradiated cerebral hemispheres were signif-
icantly increased over time since the subacute period when
compared with those in the sham operation group. These
results are consistent with the report that the functions of
VEGF and FGF2 are not fixed, but rather have a multidirec-
tional nature depending on given cells, tissues, and their con-
ditions. In this manner, they relate to the proliferation of astro-
cytes, vascular endothelial cells, and necrosis usually shown
after irradiation and contribute to the radiation injury. In
Upregulation of VEGF and FGF2 after Experimental IORT 885summary, we demonstrated that the radiation injuries after
IORT, as used for various malignant tumors these days, con-
sist of radiation necrosis, which was associated with the ex-
pression of VEGF, and FGF2. Further elucidation of the roles
of FGF2 and VEGF in relation to radiation injury, can find
appreaches for the prevention of complications after single
high-dose radiation therapy.
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